title: Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
authors.affiliation: Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.
authors.forename: Wing-Wai
authors.initials: WW
authors.lastname: Yew
authors.affiliation: Division of Clinical Infectious Diseases, Research Center Borstel, Center for Medicine and Biosciences, German Center for Infection Research (DZIF), Borstel, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Lange
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D000069349:Linezolid; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000472:pathogenicity; D023303:Oxazolidinones / Q000627:therapeutic use*; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000081:Acetamides; D000995:Antitubercular Agents; D023303:Oxazolidinones; D000069349:Linezolid